Erythropoiesis and iron kinetics

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Leukemia·2016

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Leukemia·2016

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Leukemia·2015

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Leukemia·2015

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

British journal of haematology·2026

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

British journal of haematology·2026

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

British journal of haematology·2026

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

British journal of haematology·2026

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

British journal of haematology·2026

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

British journal of haematology·2026

<i>Clostridioides difficile</i> Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.

Open forum infectious diseases·2026

Dysphagia Aortica Secondary to a Giant Aortic Aneurysm: An Old Sign Revisited.

Cureus·2026

Liver Iron Content in Individuals With B-Thalassemia Trait and Hyperferritinemia: Role of Metabolic Alterations, <i>HFE</i> Genotypes, and Cirrhosis.

Mediterranean journal of hematology and infectious diseases·2026

Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation.

Frontiers in nutrition·2026

Association between vitamin D deficiency and longitudinal risk of head and neck cancer: a multi-institutional retrospective study.

Frontiers in nutrition·2026

Association between triglyceride-to-high-density lipoprotein cholesterol ratio and albuminuria in patients with type 2 diabetes: a cross-sectional study.

Frontiers in nutrition·2026

Related Experiment Videos

Erythropoiesis and iron kinetics

Related Concept Videos

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

<i>Clostridioides difficile</i> Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.

Dysphagia Aortica Secondary to a Giant Aortic Aneurysm: An Old Sign Revisited.

Liver Iron Content in Individuals With B-Thalassemia Trait and Hyperferritinemia: Role of Metabolic Alterations, <i>HFE</i> Genotypes, and Cirrhosis.

Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation.

Association between vitamin D deficiency and longitudinal risk of head and neck cancer: a multi-institutional retrospective study.

Association between triglyceride-to-high-density lipoprotein cholesterol ratio and albuminuria in patients with type 2 diabetes: a cross-sectional study.

Related Experiment Videos

Erythropoiesis and iron kinetics

Related Concept Videos

Related Articles